As the seven-member angiopoietin-like proteins (ANGPTL) family had been previously shown to promote the hemopoietic repopulation ability of HSCs acting through LILRB2 and PIRB [51, 52], the effects of this signaling axis were examined in AML. This evidence concerns the gene LILRB3 and acute myeloid leukemia.